Test Price
700 AED✅ Home Collection Available
RSV A (RNA Detection) Qualitative Test in UAE | 700 AED | DHA Certified Molecular Diagnostics
Executive Summary & Core Metrics
- ✓ 99.9% Diagnostic Sensitivity – Real‑Time RT‑qPCR with confirmatory Whole Genome Sequencing delivers gold‑standard accuracy for detecting Respiratory Syncytial Virus A RNA in respiratory specimens.
- ✓ Home Collection with Cold‑Chain Integrity – ISO‑certified temperature‑controlled specimen transport from your location, available daily 8 AM to 11 PM, ensuring sample viability for PCR analysis.
- ✓ Rapid Turnaround & Clinical Support – Phone result within 36 hours, email within 48 hours, plus complimentary telephonic post‑test counselling by a DHA‑licensed clinician.
- ✓ Direct Insurance Pre‑Authorisation – Forward your policy via WhatsApp to +971 54 548 8731 for instant verification and coverage confirmation.
This molecular assay provides definitive qualitative detection of RSV‑A RNA, enabling clinicians to differentiate RSV‑A from other respiratory viral pathogens and initiate appropriate antiviral or supportive therapy without delay. The test is fully compliant with DHA diagnostic standards and UAE data protection legislation.
Test Overview & Methodology
The RSV A RNA Qualitative Test utilises real‑time reverse transcription polymerase chain reaction (RT‑qPCR) targeting conserved regions of the RSV‑A genome, followed by confirmatory Whole Genome Sequencing. This dual‑method approach achieves a limit of detection of 1–2 RNA copies per reaction, delivering 99.9% sensitivity and near‑absolute specificity for ruling in or ruling out active RSV‑A infection from nasopharyngeal swab or sputum specimens.
| Feature | Our RSV‑A RNA PCR (DHA Certified) | Rapid Antigen Test |
|---|---|---|
| Methodology | Real‑Time RT‑qPCR + WGS confirmation | Lateral flow immunochromatography |
| Diagnostic Sensitivity | 99.9% (LOD: 1‑2 RNA copies/reaction) | ~50–70% (high false‑negative rate) |
| Result Turnaround | 36–48 hours (phone/email) | 15–30 minutes |
| Regulatory Recognition | DHA/MOHAP standard; ICD‑10 & LOINC‑linked report | Limited; often requires PCR confirmation per DHA guidelines |
Physician Insight & Safety Protocols
“A negative RSV‑A PCR result provides strong evidence against active viral replication when an adequate specimen is collected. However, clinicians should remain vigilant for early‑stage infection or co‑infection with other respiratory pathogens. Always interpret the result alongside the full clinical picture—fever pattern, cough characteristics, oxygen saturation, and chest auscultation findings. For high‑risk patients, a repeat test or expanded respiratory panel may offer additional diagnostic clarity. Your safety and accurate diagnosis are our shared priority.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
⚠ Critical Advisory for Patients
Do not discontinue or alter any prescribed medication without consulting your treating physician. This diagnostic test is intended to complement, not replace, a comprehensive medical evaluation.
Exclusion Criteria & Red Flags
- Exclusion from home collection: Patients with active severe epistaxis, recent orofacial trauma, or known bleeding diathesis should have specimen collection performed in a clinical setting under medical supervision.
- Emergency red flags – Seek immediate ER care if you experience: sudden onset of severe shortness of breath, cyanosis (blue lips or face), altered consciousness, or haemodynamic instability.
- Paediatric requirement: For patients under 18 years, written consent from a legal guardian is mandatory in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. How accurate is the RSV A RNA qualitative test for ruling out infection?
The test achieves 99.9% diagnostic sensitivity, meaning a negative result effectively excludes active RSV‑A replication when an adequate nasopharyngeal or sputum specimen is obtained. Pre‑analytical variables such as improper swab technique or sampling during very early infection may rarely yield false negatives; repeat testing is advised if clinical suspicion persists. This PCR‑based method is the gold standard endorsed by DHA for definitive diagnosis of RSV‑A.
2. What should I do to prepare for home specimen collection?
No fasting, dietary restriction, or medication adjustment is required. Please have your Emirates ID and a signed consent form ready, together with any clinical records documenting symptom onset and prior treatments. Our trained healthcare professional will collect a nasopharyngeal swab or sputum sample using a certified cold‑chain kit, ensuring optimal specimen integrity for accurate PCR analysis.
3. How long does it take to receive my results, and how will they be communicated?
Preliminary results are available by phone within 36 hours of sample collection, with a detailed electronic report emailed within 48 hours. A DHA‑licensed clinician will provide a complimentary telephonic post‑test consultation to discuss your results and recommend appropriate next steps.
4. How are my personal health data protected under UAE law?
All personal health information is encrypted and stored in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Access to your records is restricted to authorised healthcare professionals for treatment and reporting purposes only. Your data is never disclosed to third parties without your explicit consent, and our laboratory maintains ISO 9001:2015 certification for information security management.
UAE Regulatory & Data Privacy Adherence
Your privacy and diagnostic accuracy are safeguarded under the UAE’s most stringent legal frameworks. This test is performed at DNA Labs UAE, a DHA‑licensed facility (License No. 1143) operating in full conformity with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree‑Law No. 4 of 2016 on Medical Liability. All clinical procedures adhere to ISO 9001:2015 quality management standards, and your personal data are encrypted, access‑controlled, and never shared without your explicit authorisation.
Clinical & Logistical Metadata
| Test Name | RSV A (RNA Detection) Qualitative Test |
| Price (AED) | 700 AED |
| Turnaround Time | 36–48 hours (phone result within 36 h, email report within 48 h) |
| Sample Type / Matrix | Nasopharyngeal Swab or Sputum |
| Methodology Used | Real‑Time RT‑qPCR with Whole Genome Sequencing Confirmation |
| ICD-10-CM Code | B97.4 |
| LOINC Code | 62462-0 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians